Natera submits Signatera CDx PMA to FDA for bladder cancer use

Astrazeneca Imfinzi perioperative regimen gains positive EU CHMP opinion in early gastric cancer

I Peace generates human iPS cells from NKT cells and offers them for research use

Frontage expands early phase clinical research capabilities across US and China

Summit Therapeutics' BLA for ivonescimab in EGFR-mutated NSCLC accepted by FDA

InSysBio agrees new collaborative project with BeOne Medicines

Physiomics secures new modelling contract with Numab Therapeutics

HanchorBio partners with WuXi Biologics for development and manufacturing of next-gen bi- and multi-functional fusion programmes

MS Pharma enters strategic partnership with Hetero Group

PhotonPharma adds Dr. William Warren to board

Mabwell reports first patient dosed with 7MW4911 in US trial

Atossa Therapeutics' founder and CEO named one of The Top 50 Healthcare Technology CEOs of 2025

Avacta secures FDA clearance for second pre|CISION oncology programme

Guardant Health and Merck enter multi-year oncology diagnostics collaboration

Akeso secures NMPA review acceptance for gumokimab in ankylosing spondylitis